Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

Pharmaceutical company Novo Nordisk is waiting on federal approval to sell its blockbuster GLP-1 weight-loss treatment as a ...

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

While they share similarities, there are differences, particularly between the drugs semaglutide and tirzepatide.

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Novo Nordisk A/S (NYSE: NVO) is seeking FDA approval for the pill version of its obesity drug, Wegovy. The company highlights ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

Ozempic, Wegovy and Mounjaro can still be expensive, but pharmacy-produced GLP-1 compounds are becoming much more affordable.

Trump administration has rejected Biden proposal to expand coverage Medicare currently covers Ozempic, Mounjaro solely for diabetes Wegovy, Zepbound not covered for weight loss Trump ...

The weight-loss drug revolution is reshaping the health and wellness industry, forcing companies to adapt or face the same ...